Izeen Pharma

Frederick, United States Founded: 2014 • Age: 12 yrs
Specializes as a CDMO offering orally disintegrating dosage forms and advanced delivery systems.

About Izeen Pharma

Izeen Pharma was a Healthcare company based in Frederick (United States) founded in 2014. It specializes as a CDMO offering orally disintegrating dosage forms and advanced delivery systems. It operates on a B2B model. Its Indian entity Izeen Pharma Limited reported revenue of β‚Ή6.3 Lakh. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Contract Manufacturing and Dosage Form Development. Its competitors include Asymchem, Aptuit and Continuus Pharma; 2 of its 3 listed competitors have raised funding.

Company details

Izeen Pharma, founded in 2014 in Frederick, United States, focuses on providing healthcare solutions, producing pharmaceutical products, contract manufacturing, and dosage form development. Specializes as a CDMO offering orally disintegrating dosage forms and advanced delivery systems. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Key Metrics
  • Indian entity revenue
    ₹6.3 Lakh

    FY 2016

  • Indian entity net loss
    -₹3.5 Lakh

    FY 2016 · -57% margin

  • Indian entity EBITDA
    -₹3.5 Lakh

    FY 2016 · -55% margin

Board of directors of Izeen Pharma Limited (Izeen Pharma)

Izeen Pharma Limited is the primary company behind Izeen Pharma. The board of Izeen Pharma Limited currently have 3 directors; the longest-serving is Vasudev Komaraju, appointed in 2015. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vasudev Komaraju
DIN 07233691
Director04 Jul 201511 yrs 4 moIzeen Pharma Limited
Sree Rama Ratan Volety
DIN 08048264
Director01 Apr 20179 yrs 7 moIzeen Pharma Limited
Ramkumar Sarma Vishnubhotla
DIN 07950631
Director10 Dec 20187 yrs 11 moIzeen Pharma Limited

Financials of Izeen Pharma

Figures of Izeen Pharma Limited, the primary company behind Izeen Pharma, for FY 2016. Revenue was ₹6.3 Lakh. Net loss was -₹3.5 Lakh (-57% margin). EBITDA was -₹3.5 Lakh (-55% margin).

  • ₹6.3 LakhRevenue · FY 2016
  • -₹3.5 LakhNet loss · -57% margin
  • -₹3.5 LakhEBITDA · -55% margin
  • ₹2.56 CrPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Izeen Pharma Limited are on its company page.

Premium access

Detailed financial statements for Izeen Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Izeen Pharma

Izeen Pharma has 3 listed competitors in our database, 2 of them funded. They include Asymchem, Aptuit and Continuus Pharma.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
asymchem.com1995Morrisville, United States48
APIs and peptides are developed and manufactured by Asymchem.
aptuit.com2004Greenwich, United States$14.23M
Contract research and development services for small molecules are offered.
continuuspharma.com2012Woburn, United States$7.73M47
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development
Premium access

Detailed competitors of Izeen Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as Izeen Pharma (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 5.33 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Izeen Pharma

Izeen Pharma was founded in 2014.

Izeen Pharma is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.

The primary company behind Izeen Pharma, Izeen Pharma Limited, reported revenue of β‚Ή6.3 Lakh for FY 2016.

Izeen Pharma, founded in 2014 in Frederick, United States, focuses on providing healthcare solutions, producing pharmaceutical products, contract manufacturing, and dosage form development. Specializes as a CDMO offering orally disintegrating dosage forms and advanced delivery systems. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Izeen Pharma's top competitors include Asymchem, Aptuit and Continuus Pharma.

Izeen Pharma operates through Izeen Pharma Limited.

The legal entities of Izeen Pharma currently have 3 directors, including Vasudev Komaraju, Sree Rama Ratan Volety, Ramkumar Sarma Vishnubhotla.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available